Skip to main content
Erschienen in: Immunologic Research 3/2022

20.01.2022 | Original Article

Association of IGHM polymorphisms with susceptibility to type 1 diabetes

verfasst von: Zouidi Ferjeni, Fakhfakh Raouia, O. Abida, C. Penha-Gonçalves, H. Masmoudi

Erschienen in: Immunologic Research | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Differentiation of B lymphocytes is accompanied by a regulated switch in the expression pattern and stability of surface and secretory immunoglobulins (Igs). Several lines of evidence show that autoimmune responses evolving in much autoimmune pathologies were associated with a high level of humoral Ig, but their pathogenic role remains elusive. The aim of this study was to test the hypothesis that variants at the immunoglobulin heavy-chain IGH locus are genetic determinants to T1D susceptibility. Here, we tested the genetic association of the variants of the immunoglobulin heavy-chain IGH locus as a genetic determinant to T1D susceptibility. A total of 255 subjects from 59 Tunisian families were genotyped for 15 SNPs mapping in 4 regions in IGH locus. We found that rs1950942, rs2180790, rs1808152, and rs1956596 of IGHM and rs2516751 variant located in the IGHA1/IGHG2 region were significantly associated with a risk for T1D p = 7E-3; p = 0.03; p = 0.02; p = 0.043; and p = 3.65E-5, respectively. The TATGG haplotype derived from LD across three SNPs from IGHM gene and two SNPs from IGHD gene was significantly over-transmitted from parents to affect offspring. Our results suggest that genetic variants at the IGH locus are associated with T1D susceptibility. These variations may predispose to IgG AutoAbs production against pancreatic antigens and AutoAbs multi-reactivity, leading to T1D development.
Literatur
1.
Zurück zum Zitat Watson CT, Breden F. The immunoglobulin heavy chain locus: genetic variation, missing data, and implications for human disease. Genes Immun. 2012;13(5):363–73.CrossRef Watson CT, Breden F. The immunoglobulin heavy chain locus: genetic variation, missing data, and implications for human disease. Genes Immun. 2012;13(5):363–73.CrossRef
2.
Zurück zum Zitat Robinson WH. Sequencing the functional antibody repertoire—diagnostic and therapeutic discovery. Nat Rev Rheumatol. 2015;11(3):171.CrossRef Robinson WH. Sequencing the functional antibody repertoire—diagnostic and therapeutic discovery. Nat Rev Rheumatol. 2015;11(3):171.CrossRef
3.
Zurück zum Zitat Lefranc M-P, Lefranc G. The immunoglobulin factsbook. Academic press; 2001. Lefranc M-P, Lefranc G. The immunoglobulin factsbook. Academic press; 2001.
4.
Zurück zum Zitat Stavnezer J, Guikema JE, Schrader CE. Mechanism and regulation of class switch recombination. Annual review of immunology. 2008;26. Stavnezer J, Guikema JE, Schrader CE. Mechanism and regulation of class switch recombination. Annual review of immunology. 2008;26.
5.
Zurück zum Zitat Achenbach P, Warncke K, Reiter J, Naserke HE, Williams AJ, Bingley PJ, et al. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes. 2004;53(2):384–92.CrossRef Achenbach P, Warncke K, Reiter J, Naserke HE, Williams AJ, Bingley PJ, et al. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes. 2004;53(2):384–92.CrossRef
6.
Zurück zum Zitat Hoppu S, Härkönen T, Ronkainen MS, Åkerblom HK, Knip M, Group CDiFS. IA-2 antibody epitopes and isotypes during the prediabetic process in siblings of children with type 1 diabetes. Journal of autoimmunity. 2004;23(4):361–70.CrossRef Hoppu S, Härkönen T, Ronkainen MS, Åkerblom HK, Knip M, Group CDiFS. IA-2 antibody epitopes and isotypes during the prediabetic process in siblings of children with type 1 diabetes. Journal of autoimmunity. 2004;23(4):361–70.CrossRef
7.
Zurück zum Zitat Decraene T, Vandewalle C, Pipeleers D, Gorus F. Increased concentrations of total IgM at clinical onset of type 1 (insulin-dependent) diabetes: correlation with IgM binding to cells. The Belgian Diabetes Registry Clinical chemistry. 1992;38(9):1762–7.PubMed Decraene T, Vandewalle C, Pipeleers D, Gorus F. Increased concentrations of total IgM at clinical onset of type 1 (insulin-dependent) diabetes: correlation with IgM binding to cells. The Belgian Diabetes Registry Clinical chemistry. 1992;38(9):1762–7.PubMed
8.
Zurück zum Zitat Dean B, Becker F, McNally J, Tarn A, Schwartz G, Gale E, et al. Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes. Diabetologia. 1986;29(5):339–42.CrossRef Dean B, Becker F, McNally J, Tarn A, Schwartz G, Gale E, et al. Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes. Diabetologia. 1986;29(5):339–42.CrossRef
9.
Zurück zum Zitat Hawa MI, Fava D, Medici F, Deng Y-J, Notkins AL, De Mattia G, et al. Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality. Diabetes Care. 2000;23(2):228–33.CrossRef Hawa MI, Fava D, Medici F, Deng Y-J, Notkins AL, De Mattia G, et al. Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality. Diabetes Care. 2000;23(2):228–33.CrossRef
10.
Zurück zum Zitat Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol. 1995;7(6):812–8.CrossRef Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol. 1995;7(6):812–8.CrossRef
11.
Zurück zum Zitat Merbl Y, Zucker-Toledano M, Quintana FJ, Cohen IR. Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. J Clin Investig. 2007;117(3):712–8.CrossRef Merbl Y, Zucker-Toledano M, Quintana FJ, Cohen IR. Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. J Clin Investig. 2007;117(3):712–8.CrossRef
12.
Zurück zum Zitat Rolim I, Duarte N, Barata G, Costa J, Gardete-Correia L, Boavida J, et al. Immunoglobulin M gene association with autoantibody reactivity and type 1 diabetes. Immunogenetics. 2017;69(7):429–37.CrossRef Rolim I, Duarte N, Barata G, Costa J, Gardete-Correia L, Boavida J, et al. Immunoglobulin M gene association with autoantibody reactivity and type 1 diabetes. Immunogenetics. 2017;69(7):429–37.CrossRef
13.
Zurück zum Zitat Côrte-Real J, Duarte N, Tavares L, Penha-Gonçalves C. Innate stimulation of B1a cells enhances the autoreactive IgM repertoire in the NOD mouse: implications for type 1 diabetes. Diabetologia. 2012;55(6):1761–72.CrossRef Côrte-Real J, Duarte N, Tavares L, Penha-Gonçalves C. Innate stimulation of B1a cells enhances the autoreactive IgM repertoire in the NOD mouse: implications for type 1 diabetes. Diabetologia. 2012;55(6):1761–72.CrossRef
14.
Zurück zum Zitat Zouidi F, Stayoussef M, Bouzid D, Fourati H, Abida O, Ayed MB, et al. Contribution of PTPN22, CD28, CTLA-4 and ZAP-70 variants to the risk of type 1 diabetes in Tunisians. Gene. 2014;533(1):420–6.CrossRef Zouidi F, Stayoussef M, Bouzid D, Fourati H, Abida O, Ayed MB, et al. Contribution of PTPN22, CD28, CTLA-4 and ZAP-70 variants to the risk of type 1 diabetes in Tunisians. Gene. 2014;533(1):420–6.CrossRef
15.
Zurück zum Zitat Consortium WTCC. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661.CrossRef Consortium WTCC. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661.CrossRef
16.
Zurück zum Zitat Hua RX, Fu W, Lin A, Zhou H, Cheng J, Zhang J et al. Role of FTO gene polymorphisms in Wilms tumor predisposition: A five‐center case–control study. The Journal of Gene Medicine. 2021:e3348. Hua RX, Fu W, Lin A, Zhou H, Cheng J, Zhang J et al. Role of FTO gene polymorphisms in Wilms tumor predisposition: A five‐center case–control study. The Journal of Gene Medicine. 2021:e3348.
17.
Zurück zum Zitat Ren H, Zhuo Z-J, Duan F, Li Y, Yang Z, Zhang J et al. ALKBH5 gene polymorphisms and hepatoblastoma susceptibility in chinese children. Journal of oncology. 2021;2021. Ren H, Zhuo Z-J, Duan F, Li Y, Yang Z, Zhang J et al. ALKBH5 gene polymorphisms and hepatoblastoma susceptibility in chinese children. Journal of oncology. 2021;2021.
18.
Zurück zum Zitat Zhuo Z, Miao L, Hua W, Chen H, Yang Z, Li Y et al. Genetic variations in nucleotide excision repair pathway genes and hepatoblastoma susceptibility. International journal of cancer. 2021. Zhuo Z, Miao L, Hua W, Chen H, Yang Z, Li Y et al. Genetic variations in nucleotide excision repair pathway genes and hepatoblastoma susceptibility. International journal of cancer. 2021.
19.
Zurück zum Zitat Hakonarson H, Grant SF, Bradfield JP, Marchand L, Kim CE, Glessner JT, et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature. 2007;448(7153):591–4.CrossRef Hakonarson H, Grant SF, Bradfield JP, Marchand L, Kim CE, Glessner JT, et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature. 2007;448(7153):591–4.CrossRef
20.
Zurück zum Zitat Cianci R, D’Addabbo P, Gambassi G, Lolli S, Serone E, Rizzi A, et al. Association between IgH enhancer hs1 2 and type 1 diabetes. Acta diabetologica. 2018;55(5):443–8.CrossRef Cianci R, D’Addabbo P, Gambassi G, Lolli S, Serone E, Rizzi A, et al. Association between IgH enhancer hs1 2 and type 1 diabetes. Acta diabetologica. 2018;55(5):443–8.CrossRef
21.
Zurück zum Zitat Tolusso B, Frezza D, Mattioli C, Fedele AL, Bosello S, Faustini F, et al. Allele* 2 of the HS1, 2A enhancer of the Ig regulatory region associates with rheumatoid arthritis. Ann Rheum Dis. 2009;68(3):416–9.CrossRef Tolusso B, Frezza D, Mattioli C, Fedele AL, Bosello S, Faustini F, et al. Allele* 2 of the HS1, 2A enhancer of the Ig regulatory region associates with rheumatoid arthritis. Ann Rheum Dis. 2009;68(3):416–9.CrossRef
22.
Zurück zum Zitat Frezza D, Tolusso B, Giambra V, Gremese E, Marchini M, Nowik M, et al. Polymorphisms of the IgH enhancer HS1 2 and risk of systemic lupus erythematosus. Annals of the rheumatic diseases. 2012;71(8):1309–15.CrossRef Frezza D, Tolusso B, Giambra V, Gremese E, Marchini M, Nowik M, et al. Polymorphisms of the IgH enhancer HS1 2 and risk of systemic lupus erythematosus. Annals of the rheumatic diseases. 2012;71(8):1309–15.CrossRef
23.
Zurück zum Zitat Frezza D, Giambra V, Tolusso B, De Santis M, Bosello S, Vettori S, et al. Polymorphism of immunoglobulin enhancer element HS1, 2A: allele* 2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency. Annals of the rheumatic diseases. 2007;66(9):1210–5.CrossRef Frezza D, Giambra V, Tolusso B, De Santis M, Bosello S, Vettori S, et al. Polymorphism of immunoglobulin enhancer element HS1, 2A: allele* 2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency. Annals of the rheumatic diseases. 2007;66(9):1210–5.CrossRef
24.
Zurück zum Zitat Kawasaki ES. Sample preparation from blood, cells, and other fluids. PCR protocols: a guide to methods and applications. 1990;1. Kawasaki ES. Sample preparation from blood, cells, and other fluids. PCR protocols: a guide to methods and applications. 1990;1.
25.
Zurück zum Zitat Dorman JS, Bunker CH. HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: a HuGE review. Epidemiol Rev. 2000;22(2):218–27.CrossRef Dorman JS, Bunker CH. HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: a HuGE review. Epidemiol Rev. 2000;22(2):218–27.CrossRef
26.
Zurück zum Zitat Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007;39(7):857–64.CrossRef Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007;39(7):857–64.CrossRef
27.
Zurück zum Zitat Plagnol V, Howson JM, Smyth DJ, Walker N, Hafler JP, Wallace C, et al. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet. 2011;7(8):e1002216.CrossRef Plagnol V, Howson JM, Smyth DJ, Walker N, Hafler JP, Wallace C, et al. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet. 2011;7(8):e1002216.CrossRef
28.
Zurück zum Zitat Walter MA, Chambers CA, Zimmerman B, Cox DW. A multigene deletion in the immunoglobulin heavy chain region in a highly atopic individual. Hum Genet. 1990;85(6):643–7.CrossRef Walter MA, Chambers CA, Zimmerman B, Cox DW. A multigene deletion in the immunoglobulin heavy chain region in a highly atopic individual. Hum Genet. 1990;85(6):643–7.CrossRef
29.
Zurück zum Zitat Avnir Y, Watson CT, Glanville J, Peterson EC, Tallarico AS, Bennett AS, et al. IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity. Sci Rep. 2016;6(1):1–13.CrossRef Avnir Y, Watson CT, Glanville J, Peterson EC, Tallarico AS, Bennett AS, et al. IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity. Sci Rep. 2016;6(1):1–13.CrossRef
30.
Zurück zum Zitat Liu L, Lucas AH. IGH V3–23* 01 and its allele V3–23* 03 differ in their capacity to form the canonical human antibody combining site specific for the capsular polysaccharide of Haemophilus influenzae type b. Immunogenetics. 2003;55(5):336–8.CrossRef Liu L, Lucas AH. IGH V3–23* 01 and its allele V3–23* 03 differ in their capacity to form the canonical human antibody combining site specific for the capsular polysaccharide of Haemophilus influenzae type b. Immunogenetics. 2003;55(5):336–8.CrossRef
31.
Zurück zum Zitat Chang C-J, Chen C-H, Chen B-M, Su Y-C, Chen Y-T, Hershfield MS, et al. A genome-wide association study identifies a novel susceptibility locus for the immunogenicity of polyethylene glycol. Nat Commun. 2017;8(1):1–7.CrossRef Chang C-J, Chen C-H, Chen B-M, Su Y-C, Chen Y-T, Hershfield MS, et al. A genome-wide association study identifies a novel susceptibility locus for the immunogenicity of polyethylene glycol. Nat Commun. 2017;8(1):1–7.CrossRef
32.
Zurück zum Zitat Tang S-J. The R-Operon: a model of repetitive DNA-organized transcriptional compartmentation of eukaryotic chromosomes for coordinated gene expression. Genes. 2016;7(4):16.CrossRef Tang S-J. The R-Operon: a model of repetitive DNA-organized transcriptional compartmentation of eukaryotic chromosomes for coordinated gene expression. Genes. 2016;7(4):16.CrossRef
33.
Zurück zum Zitat Choi NM, Feeney AJ. CTCF and ncRNA regulate the three-dimensional structure of antigen receptor loci to facilitate V (D) J recombination. Front Immunol. 2014;5:49.CrossRef Choi NM, Feeney AJ. CTCF and ncRNA regulate the three-dimensional structure of antigen receptor loci to facilitate V (D) J recombination. Front Immunol. 2014;5:49.CrossRef
Metadaten
Titel
Association of IGHM polymorphisms with susceptibility to type 1 diabetes
verfasst von
Zouidi Ferjeni
Fakhfakh Raouia
O. Abida
C. Penha-Gonçalves
H. Masmoudi
Publikationsdatum
20.01.2022
Verlag
Springer US
Erschienen in
Immunologic Research / Ausgabe 3/2022
Print ISSN: 0257-277X
Elektronische ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-021-09252-x

Weitere Artikel der Ausgabe 3/2022

Immunologic Research 3/2022 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.